Drug Shortage Report for SPASMHALT-8
| Report ID | 3761 |
| Drug Identification Number | 02237578 |
| Brand name | SPASMHALT-8 |
| Common or Proper name | SPASMHALT-8 325mgACET/8mgCOD CAPL BL3X9 |
| Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ACETAMINOPHEN METHOCARBAMOL CODEINE PHOSPHATE |
| Strength(s) | 325MG 400MG 8MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | BL3X9 |
| ATC code | M03BA |
| ATC description | MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-03-16 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2018-12-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-03-21 | French | Compare |
| v1 | 2017-03-21 | English | Compare |
Showing 1 to 2 of 2